| Literature DB >> 36037214 |
Md Numan Islam1, Md Golam Rabby1, Md Munnaf Hossen1,2, Md Mostafa Kamal1, Md Ashrafuzzaman Zahid1, Md Syduzzaman1, Md Mahmudul Hasan1,3.
Abstract
Type 2 diabetes (T2D) has earned widespread recognition as a primary cause of death, disability, and increasing healthcare costs. There is compelling evidence that hereditary factors contribute to the development of T2D. Clinical trials in T2D have mostly focused on genes and single nucleotide polymorphisms (SNPs) in protein-coding areas. Recently, it was revealed that SNPs located in noncoding areas also play a significant impact on disease vulnerability. It is required for cell type-specific gene expression. However, the precise mechanism by which T2D risk genes and SNPs work remains unknown. We integrated risk genes and SNPs from genome-wide association studies (GWASs) and performed comprehensive bioinformatics analyses to further investigate the functional significance of these genes and SNPs. We identified four intriguing transcription factors (TFs) associated with T2D. The analysis revealed that the SNPs are engaged in chromatin interaction regulation and/or may have an effect on TF binding affinity. The Gene Ontology (GO) study revealed high enrichment in a number of well-characterized signaling pathways and regulatory processes, including the STAT3 and JAK signaling pathways, which are both involved in T2D metabolism. Additionally, a detailed KEGG pathway analysis identified two major T2D genes and their prospective therapeutic targets. Our findings underscored the potential functional significance of T2D risk genes and SNPs, which may provide unique insights into the disease's pathophysiology.Entities:
Mesh:
Year: 2022 PMID: 36037214 PMCID: PMC9423640 DOI: 10.1371/journal.pone.0268826
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Functional prediction of type 2 diabetes associated SNPs in Asian populations.
| Chr | Pos (hg38) | Variant | Motifs Changed | Selected eQTL Hits | GENCODE Genes | dbSNP Functional Annotation |
|---|---|---|---|---|---|---|
| 15 | 62104190 | rs7172432 | 7 altered motifs | 1 | 33kb 3’ of C2CD4A | - |
| 3 | 64062621 | rs831571 | PLZF | - | 5.3kb 5’ of RP11-129B22.1 | - |
| 4 | 1316113 | rs6815464 | 6 altered motifs | - | MAEA | intronic |
| 6 | 38139068 | rs9470794 | Ascl2,BHLHE40,Myf | 1 | ZFAND3 | intronic |
| 6 | 39316274 | rs1535500 | 5 altered motifs | 9 | KCNK16 | missense |
| 7 | 127524904 | rs6467136 | 5 altered motifs | 1 | 39kb 3’ of AC000124.1 | - |
| 9 | 4287466 | rs7041847 | Osr | - | GLIS3 | intronic |
| 19 | 33402102 | rs3786897 | LF-A1,SP1,SZF1-1 | 4 | PEPD | intronic |
| 20 | 44318326 | rs6017317 | CEBPA,Mef2,STAT | 4 | 7.2kb 5’ of FITM2 | - |
| 8 | 41661944 | rs515071 | 4 altered motifs | 3 | RP11-930P14.1 | intronic |
| 10 | 119389891 | rs10886471 | - | - | GRK5 | intronic |
| 15 | 38530704 | rs7403531 | Hmbox1 | 22 | RP11-275I4.1 | intronic |
| 7 | 127606849 | rs10229583 | KAP1,Maf,TCF12 | 1 | 3.4kb 3’ of PAX4 | - |
| 9 | 136357696 | rs11787792 | Pax-5,TCF12,ZNF263 | 13 | GPSM1 | intronic |
| 17 | 7037074 | rs312457 | 4 altered motifs | - | SLC16A13 | intronic |
| 3 | 186948673 | rs16861329 | RXRA,TBX5 | - | ST6GAL1 | intronic |
| 10 | 69171718 | rs1802295 | 5 altered motifs | 9 | VPS26A | 3’-UTR |
| 15 | 77454848 | rs7178572 | THAP1 | 4 | HMG20A | intronic |
| 15 | 89831025 | rs2028299 | Egr-1,Ets,Znf143 | 30 | AP3S2 | 3’-UTR |
| 20 | 44360627 | rs4812829 | Mef2,Nkx2 | 2 | HNF4A | intronic |
| 13 | 23290518 | rs9552911 | 6 altered motifs | - | SGCG | intronic |
| 2 | 134722410 | rs6723108 | Foxp3,Pou5f1,STAT | 10 | 3.4kb 5’ of TMEM163 | - |
| 2 | 164645339 | rs3923113 | HEN1 | 1 | 8.3kb 3’ of COBLL1 | - |
Fig 1Functional prediction and protein-protein interaction of T2D risk genes and SNPs.
(A) Transcription factors (TF) enrichment, TFs are sorted based on their enrichment. (B) Protein-protein interaction of T2D risk genes. In protein-protein interaction, connections are based on co-expression and experimental evidence. Each filled node denotes a gene; edges between nodes indicate protein-protein interactions between protein products of the corresponding genes. Different edge colors represent the types of evidence for the association.
The most significant gene ontology (GO) terms for type 2 diabetes associated SNPs target genes.
| ID | Name | p-value | Genes from Input | Genes in Annotation | |
|---|---|---|---|---|---|
| Molecular Functions | GO:0102009 | Proline dipeptidase activity | 9.80E-04 | 1 | 1 |
| GO:0102010 | Beta-galactoside alpha-2,6-sialyltransferase activity | 1.96E-03 | 1 | 2 | |
| GO:0102011 | Stearic acid binding | 1.96E-03 | 1 | 2 | |
| GO:0102012 | Transition metal ion binding | 3.88E-03 | 5 | 1130 | |
| GO:0102013 | Beta-adrenergic receptor kinase activity | 3.91E-03 | 1 | 4 | |
| GO:0102014 | G protein-coupled receptor kinase activity | 6.83E-03 | 1 | 7 | |
| GO:0102015 | Long-chain fatty acyl-CoA binding | 7.80E-03 | 1 | 8 | |
| GO:0102016 | Arachidonic acid binding | 7.80E-03 | 1 | 8 | |
| GO:0102017 | Zinc ion binding | 8.32E-03 | 4 | 849 | |
| GO:0102018 | Icosatetraenoic acid binding | 8.78E-03 | 1 | 9 | |
| Biological Processes | GO:1904145 | Negative regulation of meiotic cell cycle process involved in oocyte maturation | 9.90E-04 | 1 | 1 |
| GO:0031018 | Endocrine pancreas development | 1.75E-03 | 2 | 63 | |
| GO:1902569 | Negative regulation of activation of Janus kinase activity | 1.98E-03 | 1 | 2 | |
| GO:0062111 | Zinc ion import into organelle | 1.98E-03 | 1 | 2 | |
| GO:0099180 | Zinc ion import into synaptic vesicle | 1.98E-03 | 1 | 2 | |
| GO:1903537 | Meiotic cell cycle process involved in oocyte maturation | 2.97E-03 | 1 | 3 | |
| GO:1903538 | Regulation of meiotic cell cycle process involved in oocyte maturation | 2.97E-03 | 1 | 3 | |
| GO:0002528 | Regulation of vascular permeability involved in acute inflammatory response | 3.95E-03 | 1 | 4 | |
| GO:0031016 | Pancreas development | 4.26E-03 | 2 | 99 | |
| GO:0006520 | Cellular amino acid metabolic process | 4.53E-03 | 3 | 349 |
Fig 2Key genes pathway identification and potential drug design.
(A) KEGG pathway enrichment. PAX4 and HNF4A genes were significantly enriched in the maturity onset diabetes of the young. (B and C) HNF4A and PAX4 are each linked to different potential drugs. Green node: the drug decreases the key gene expression; and red node: the drug increases the expression of the key gene.